Press release
Investigation announced for Investors who lost money with shares of Acadia Healthcare Company Inc (NASDAQ: ACHC)
An investigation for investors in Acadia Healthcare Company Inc (NASDAQ: ACHC) shares over potential securities laws violations.
Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Acadia Healthcare Company Inc (NASDAQ: ACHC) concerning whether a series of statements by Acadia Healthcare Company Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Franklin, TN based Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.
Acadia Healthcare Company Inc reported that its annual Total Revenue rose from over $2.61 billion in 2022 to over $2.92 billion in 2023, and that its Net Income of $273.13 million in 2022 declined to a Net Loss of $21.66 million in 2023.
On Sunday, September 1, 2024, The New York Times published an investigative report titled "How a Leading Chain of Psychiatric Hospitals Traps Patients." The report highlighted that Acadia Healthcare Company Inc, one of the largest psychiatric hospital chains in the U.S., saw a significant increase in revenue during the pandemic-driven mental health crisis. However, the investigation revealed troubling practices, including allegations that Acadia detained patients against their will without medical necessity. In at least 12 of the 19 states where Acadia operates, numerous patients, employees, and police officers reported these unlawful detentions to authorities. In some instances, judges had to intervene to secure the release of patients.
Shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) declined from $82.41 per share on August 30, 2024, to as low as $75.46 per share on September 11, 2024.
Those who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors who lost money with shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) here
News-ID: 3658561 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for Investors who lost money with shares of STMicroelectronics N.V …
An investor, who purchased shares of STMicroelectronics N.V. (NYSE: STM), filed a lawsuit over alleged violations of Federal Securities Laws by STMicroelectronics N.V. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of STMicroelectronics N.V. (NYSE: STM) have certain options and for certain investors are short and strict deadlines running. Deadline: October 22, 2024. NYSE: STM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Investors who hold shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) long …
The Shareholders Foundation, Inc. announces that a lawsuit is currently pending by an investor in NASDAQ: REGN shares against certain directors of Regeneron Pharmaceuticals, Inc.
Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) long-term and continue to hold any of those NASDAQ: REGN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
In June 2021 an investor in NASDAQ: REGN…
Deadline coming up on Sept. 27th in Lawsuit for Investors who lost money with Li …
A deadline is coming up on September 27, 2024 in the lawsuit filed for certain investors of Lifecore Biomedical, Inc. (NASDAQ: LFCR) over alleged securities laws violations by Lifecore Biomedical, Inc.
Investors who purchased shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) have certain options and there are strict and short deadlines running. Deadline: September 27, 2024. NASDAQ: LFCR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of DigitalOcean Holdin …
An investigation was announced on behalf of current long-term investors in shares of DigitalOcean Holdings, Inc. (NYSE: DOCN) concerning potential breaches of fiduciary duties by certain directors and officers of DigitalOcean Holdings, Inc..
Investors who are current long term investors in DigitalOcean Holdings, Inc. (NYSE: DOCN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for…
More Releases for Acadia
Glaucoma Pharmaceuticals Market to Witness Huge Growth by 2027 | Allergan, Merck …
The Latest survey report on Glaucoma Pharmaceuticals Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Glaucoma Pharmaceuticals organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Acadia Pharmaceuticals Inc., Allergan Inc., Inotek Pharmaceuticals Corporation, Merck & Co. Inc., Santen…
2021-2027 Behavioral Health Market Report- Size by Application: Acadia Healthcar …
The Behavioral Health Market research report Provides detailed information about new product launches, reimbursement scenarios in crucial countries, research methodology, recent developments, market segmentation, and investments. Moreover, Behavioral Health Market also Scrutinizes top to bottom worldwide market patterns and perspectives combined with the driving components of the market.
Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4997844
By Company
- Acadia Healthcare
- CareTech Holdings
- The MENTOR Network
- Universal Health Services
- Behavioral Health…
Investigation announced for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ACADIA Pharmaceuticals Inc..
Investors who are current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ACAD stocks follows a lawsuit filed against ACADIA…
Lawsuit filed for Investors in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investor, who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), filed a lawsuit over alleged violations of Federal Securities Laws by ACADIA Pharmaceuticals Inc.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Diego, CA based…
Investigation announced for Investors in shares of ACADIA Pharmaceuticals Inc. ( …
ACADIA Pharmaceuticals Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by ACADIA Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false…
Investigation announced for Long-Term Investors in Acadia Healthcare Company Inc …
An investigation was announced for investors in shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) concerning potential breaches of fiduciary duties by certain directors at Acadia Healthcare Company Inc.
Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) and currently hold any of those NASDAQ: ACHC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
